Overall impact
D (38)

Commentary

Bachem is a below-average overall performer. With a 'D' rating of 37.8 for overall impact (bottom 25% of all companies), Bachem ranks 98th out of 151 industry peers, behind Amyris, Aemetis, Northern Technologies International and 94 others, and ahead of Oil-Dri of America, Mitsubishi Gas Chemical Inc, China Jushi and 50 others. On top material causes for Bachem's industry (Chemicals), Bachem performs poorly in Sustainable Use of Water (15.1 score), Sustainable Use of Natural Resources (16.2), Sanitation Access (24.5) and 6 other causes where it received a 'D' or 'F' score. Bachem did not receive an 'A' rating on any cause.
Impact
Cause BANB.SW
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Employees
2,725
Sector
Materials
Industry
Chemicals
Sub-industry
Specialty Chemicals
SASB industry
Chemicals
Headquarters
Switzerland
Share classes
BANB.SW
BCHMY
ADR
Description
Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. It engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). The company also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, and supply and vertical integration services. Bachem Holding AG was incorporated in 1971 and is headquartered in Bubendorf, Switzerland.
Material causes
Ethos considers the following causes material for Bachem, based on its industry sub-industry Specialty Chemicals. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.